Does Humana Cover Rehab?

Humana operates as Medicare-skewed book of business, with 17+ million (heavily Medicare Advantage) covered across nationwide; largest in the Southeast, Texas, Florida, Kentucky. Its parity compliance framework is enforced under MHPAEA; specific medical-necessity criteria must — under the 2024 Final Rule — be disclosed to plan participants upon request. The paragraphs that follow disaggregate the practical coverage framework.

Parity enforcement — what the 2024 rule changed

Humana's medical-necessity criteria must, under the 2024 Final Rule, align with generally accepted clinical standards of care — including ASAM Criteria for levels of care, SAMHSA TIPs for specific interventions, and DSM-5-TR for diagnostic terminology. Humana's compliance posture is mid-range — neither the most restrictive of the majors nor the most permissive — and the experience varies meaningfully by specific plan product. Departures from these consensus standards are actionable under the rule's enforcement framework.

Humana plan types

Humana's products (Medicare Advantage, Commercial HMO, Commercial PPO, TRICARE East (in region), Medicaid managed (in select states)) carry variable benefit designs within a common regulatory framework. For addiction-treatment planning, the operative variables are: (1) deductible status at time of admission; (2) in-network versus out-of-network cost-share; (3) prior-authorization requirements; (4) medical-necessity criteria applied. All four should be documented in writing from Humana member services before admission.

A note on medication-assisted treatment

MAT coverage under Humana operates through a pharmacy-benefit layer (Part D equivalent for retail-dispensed medications) and a medical-benefit layer (for methadone dispensed via federally-licensed opioid treatment programs and for Vivitrol or Sublocade administration). Part B equivalent covers MAT medication and administration; Part D covers pharmacy-dispensed buprenorphine-naloxone The coverage distinction is operationally important because denials at the pharmacy-benefit layer and at the medical-benefit layer follow different appeal pathways.

When Humana denies — appeal playbook

Appeal strategy for Humana denials should focus on three documents: (1) the specific medical-necessity criteria applied in the denial (disclosable under 2024 parity rule on request within 10 business days); (2) the comparative analysis Humana produced demonstrating parity compliance for the non-quantitative treatment limit in question; (3) an ASAM 4e-aligned clinical assessment from an independent treating clinician. Appeals that cite specific criteria against specific clinical documentation have substantially higher reversal rates than appeals that argue clinical judgment in general terms.

Before admission

Pre-admission operational checklist for Humana: (1) obtain current Summary of Benefits and Coverage from member services (1-800-457-4708); (2) obtain written medical-necessity criteria for the proposed level of care (disclosable under 2024 parity rule); (3) obtain written Verification of Benefits from the proposed facility's utilization-review team; (4) confirm in-network status for the specific Humana product; (5) confirm prior-authorization status and turnaround. Proceeding without these five documents creates material risk of post-admission benefit dispute.